Development of novel lyophilized mixed micelle amphotericin B formulation for treatment of systemic fungal infection

Current Drug Delivery

Volumn 2, Issue 2, 2005, Pages 177-184

  Naik, Sachin ^a   Chougule, Mahavir ^a   Padhi, Bijay Kumar ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Amphotericin B; Hemolytic activity; Minimum inhibitory concentration; Mixed micelles; Monomeric form; Mortality

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; DEOXYCHOLATE SODIUM; PHOSPHATIDYLCHOLINE; TAUROCHOLIC ACID;

ANAPHYLAXIS; ARTICLE; BLOOD TOXICITY; CANDIDA ALBICANS; CHILL; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEVER; FREEZE DRYING; FUNGICIDAL ACTIVITY; HEMOLYSIS; HUMAN; HUMAN CELL; HYPOKALEMIA; HYPOTENSION; MICELLE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; RIGOR; SIDE EFFECT;

AMPHOTERICIN B; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREEZE DRYING; HUMANS; MALE; MICELLES; MICROBIAL SENSITIVITY TESTS; MYCOSES; RATS;

EID: 17044374729     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567201053586056     Document Type: Article

References (34)

1. Fridkin, S. K.; Jarvis, W. R. Clin. Microb. Rev., 1996, 9, 499-511.
2. Garber, G. Drugs, 2001, 61, Suppl. 1, 1-12.
3. Ellis, M. Molecular Immunology, 2002, 38, 947-957.
4. Baley, J.E.; Annable, W.I.; Kaliegman, R.M.; J. Pediatrics, 1981, 95, 458-461.
5. Johnson, D.E.; Thompson, T.R.; Green, T.P.; Ferrieri, P. Pediatrics, 1984, 73, 138-143.
6. Mcevoy, G.K.; AHFS 96 Drug Information, American society of health-system pharmacists, BetheSEMa, 1996.
7. Hiemenz, J.W.; Walsh, T.J. Clin. Infect. Dis., 1996, 22 (S-2), 133-144.
8. Peacock, J. E.; Herrington, D.A.; Cruz J.M. Infect Dis Clin Pract., 1993, 2, 81-93.
9. Tolins; Raij, A.M.J. Kidney Dis., 1988, 11 (4), 313-317.
10. Walsh, T. J.; Gonzalez, C.; Lyman, C.A; Chanock, S.J.; Pizzo P.A. Adv. Pediatr. Infect. Dis., 1996, 11, 187-290.
11. Dollery, C. Therapeutic Drugs, Churchill Livingstone, New York, 1991.
12. Van Etten E. W.; Ten Kate M. T.; Stearne L. E.; Bakker-Woudenberg, I. A. Antimicrob. Agents Chemother., 1995, 39(9), 1954-1958.
13. Sharma, A., Sharma, U.S. Intern. J. Pharma., 1997, 154(2), 123-140.
14. Kotwani, A.; Prafulla, C.; Gokhale, A.; Prashant, V.; Bodhe, A.; Babita, G.; Kirodian, A.; Nilima, A.; Kshirsagar; Sunil K. Pandya. Inter. J. Pharma., 2002, 238, 11-15.
15. Hossain, M.A.; Maesaki, S.; Kakeya, H.; Noda, T.; Yanagihara, K.; Sasaki, E.; Hirakata, Y.; Tomono, K.; Tashiro, T.; Kohno, S. Inter. J. Pharma., 1999, 193, 97-106.
16. Shigeru Kohno, Takakazu Otsubo, Eitaro Tanaka, Kazuo Maruyama and Kohei Hara. Adv. Drug Del. Rev., 1997, 24, 325-329.
17. Lasic, P. D. Am. Sci., 1992, 80, 20-30.
18. Adler-Moore, J. P.; Chiang, S. M.; Satorius, A.; Guerra, D.; Mcandrews, B.; Mcmanus, E. J.; Proffitt, R. T. J. Antimicrob. Chemother., 1991, 28(b), 63-71.
19. Clark, J. M.; Whitney, R. R.; Olsen, S. J.; George, R. J.; Swerdel, M. R.; Kunselman, L.; Bonner, D. P. Antimicrob. Agents Chemother., 1991, 35, 615-621.
20. Hosteller, J. S.; Clemons, K. V.; Hanson, L. H.; Stevens, D. A. Antimicrob. Agents Chemother., 1992, 36, 2656-2660.
21. Takakazu, O.; Shigefumi M.; Mohammad A. H. et al. Antimicrob. Agents Chemother., 1999, 43(3), 471-475.
22. Van Etten, E. W. M.; Otte-Lambillion, M.; Van Vianen, W. et al. J. Antimicrob. Chemother., 1995, 35, 509-519.
23. Van Etten, E. W. M.; Van Vianen, W.; Hak, J. et al. Antimicrob. Agents Chemother., 1998, 42, 2437-2439.
24. Cabral, D.J.; Small, D.M. Physical chemistry of bile. In Handbook of physiology- The gastrointestinal system III, section 6, American Physiology Society, Waverly Press, New York, 1989, 621-661.
25. Wiedmann, T. S.; Wei Laiang; Kamel, L. Pharma. Res., 2002, 19(8), 1203-1208.
26. Walsh, T.J.; Hiemenz, J.W.; Seibel, N.; Perfect, J.R.; Horwith, G.; Lee, L.; Silber, J.L.; DiNubile, M.J.; Reboli, A.; Bow, E.; Lister, J.; Anaissie, E.J. Clin. Infect. Dis., 1998, 26, 1383-1396.
27. Brajtburg, J.; Bolard, J. Clin. Microbiol. Rev., 1996, 9(4), 512-531.
28. Brajtburg, J.; Elberg, S.; Travis, S.J.; Kobayashi, G.S. Antimicrob. Agents Chemother., 1994, 38(2), 294-299.
29. Barwicz, J.; Christian, S.; Gruda, I. Antimicrob. Agents Chemother., 1992, 36, 2310-2315.
30. Brajtburg, J.; Elberg, S.; George, S.; Kobayashi, Bolard, J. Antimicrob. Agents Chemother., 1990, 2415-2416.
31. Cannon, B.; Williams I, N. A.; Karen, J. P. Inter. J. Pharma., 1995, 114, 65-74.
32. Chong-Kook, K.; Yong-Yeon, H.; Jung-Yun, C.; Han-Gon, C.; Soo-Jeong, L.; Mi-kyungle. Inter. J. Pharmac., 2001, 4, 220 (1-2), 141-147.
33. Zhu, L.; Zhu, J.B.; Tu, Y.; Tian, X. Yao Xue Xue Bao., 2004, 39 (3), 220-222.
34. Manfred, D.; Jorg, H.; Josel, P.; Lohr, Eur. J. Pharm. Biopharm., 1998, 40(3) 147-158.